Omnicell Acquires Pharmaceutical Strategies Group's 340B Link Business from Blue Wolf Capital

EPIC Insurance Brokers & Consultants Acquires Pharmaceutical Strategies Group

February 3, 2021

Healthcare Services

EPIC Insurance Brokers & Consultants has agreed to acquire Pharmaceutical Strategies Group (PSG), the nation’s largest independent pharmacy benefit consulting firm, and will integrate PSG into its Employee Benefits Consulting practice. PSG — which reports generating more than $4.8 billion in drug cost savings for clients annually — will operate as “Pharmaceutical Strategies Group – an EPIC company,” with PSG leadership remaining in place to continue developing drug management solutions.

RxStrategies Acquired by Mid‑Market Private Equity Firm

September 24, 2019

Healthcare Services

Berkery Noyes announced it represented RxStrategies in its acquisition by a mid‑market private equity firm. RxStrategies is a provider of technology and cloud‑based analytics for 340B program administration, serving hospitals, health systems, clinics and contract pharmacies.

Blue Wolf Capital Acquires Seven Recipharm OSD Sites and Agrees to Buy Synerlab to Create New CDMO Platform

April 2, 2024

Pharmaceuticals

Blue Wolf Capital Partners has agreed to acquire seven oral solid dosage (OSD) manufacturing and development facilities from Recipharm (located in Sweden, France and Spain) and has also agreed, subject to regulatory approvals, to acquire Synerlab, a Strasbourg-based CDMO. The transactions are intended to form a new independent CDMO platform (headquartered in the UK) that expands Blue Wolf's pharmaceutical manufacturing capabilities and commercial reach across Europe.

Aquiline Makes Majority Investment in Pharma Force Group LLC

December 31, 2023

Healthcare Services

Aquiline Capital Partners has made a majority investment in Pharma Force Group LLC, a U.S.-based provider of 340B administration software and pharmacy benefits management solutions. The partnership will support PharmaForce’s product expansion and strategic M&A plans to accelerate growth across hospitals and health clinics. Piper Sandler advised PharmaForce; transaction closed in Q4 2023 with financial terms undisclosed.

WestView Capital Partners Invests Growth Capital in PharmaLink

July 21, 2025

Healthcare Services

WestView Capital Partners has made a growth investment in PharmaLink, a Largo, Florida–based pharmaceutical reverse logistics platform. The capital will support PharmaLink's expanded operations center, planned automation, and continued scaling of its return, recall and disposal services across the healthcare supply chain.

Infinity Capital Partners Acquires Soundlink Partners

May 15, 2025

Financial Services

Infinity Capital Partners has acquired Soundlink Partners, a boutique investment firm focused on healthcare and biotech investment strategies. The deal expands Infinity's sector-specific capabilities in healthcare and biotech and combines the teams to pursue new product development, co-investments, and broader distribution across Infinity's platform.